- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
CDC says steer clear of turtles; FDA names first Human Foods Program head; Upcoming Lyme disease vaccine for humans
The top news stories in primary care today.
doctor morning desk © Alena Kryazheva - stock.adobe.com
CDC says steer clear of turtles
Public health officials are investigating a 26-state outbreak of salmonella they believe is linked to small turtles. Pet turtles of any size can carry salmonella in their droppings, but fully grown turtles with less than 4-inch shells are known vectors. So far there have been nine hospitalizations from the outbreak, but no deaths.
FDA names first Human Foods Program head
The Food and Drug Administration announced James “Jim” Jones as their first ever deputy commissioner of human foods following last years’ baby formula shortage caused by contamination. Jones will start his role on Sept. 24 and oversee food safety, chemical safety, and nutrition.
Upcoming Lyme disease vaccine for humans
Lyme disease vaccines are no longer just for the dogs. The surge of Lyme disease in recent years has prompted scientists to develop another vaccine for Lyme disease. This vaccine, unlike its late '90s predecessor Lymerix, will target 6 strains of bacteria instead if just one. The vaccine will also be safe for children. Phase III trials are set to wrap up in 2025.
